Biora Therapeutics Home
Activate the mobile navigation

Publications

A scintigraphic study to evaluate the localization and delivery function of a Drug Delivery System (DDS) device in patients with active ulcerative colitis in fasted state
#Targeted Therapeutics
A scintigraphic study to evaluate the safety, tolerability, and functionality of a Drug Delivery System (DDS) device in healthy volunteers in fasted state
#Targeted Therapeutics
Pilot study to assess pharmacokinetic and pharmacodynamic markers following enema-dosing with adalimumab in patients with active ulcerative colitis
#Targeted Therapeutics
Pharmacokinetic stratification of cytokine profiles during anti-TNF induction treatment in moderate-to-severe ulcerative colitis
#Targeted Therapeutics
Tofacitinib tissue exposure correlates with endoscopic outcome
#Targeted Therapeutics
Development of a novel drug delivery system to deliver drugs directly to the colonic mucosa
#Targeted Therapeutics
Development of a novel drug delivery system for targeted treatment of ulcerative colitis
#Targeted Therapeutics
Targeted delivery of tofacitinib citrate to the site of disease to improve efficacy and safety
#Targeted Therapeutics
Targeted topical anti-α4β7 integrin antibody results in reduced accumulation of α4β7 memory T-cells in gut tissue in DSS-induced colitis mice
#Targeted Therapeutics